ATE473271T1 - Vektoren und zellen zur herstellung von aus transgenen pflanzen gewonnenen immunprotektiven zusammensetzungen - Google Patents

Vektoren und zellen zur herstellung von aus transgenen pflanzen gewonnenen immunprotektiven zusammensetzungen

Info

Publication number
ATE473271T1
ATE473271T1 AT04751538T AT04751538T ATE473271T1 AT E473271 T1 ATE473271 T1 AT E473271T1 AT 04751538 T AT04751538 T AT 04751538T AT 04751538 T AT04751538 T AT 04751538T AT E473271 T1 ATE473271 T1 AT E473271T1
Authority
AT
Austria
Prior art keywords
vectors
cells
producing
transgenic plants
compositions obtained
Prior art date
Application number
AT04751538T
Other languages
English (en)
Inventor
Guy Cardineau
Hugh Mason
Joyce Vaneck
Dwayne Kirk
Amanda Walmsley
Original Assignee
Thompson Boyce Plant Res
Dow Agrosciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thompson Boyce Plant Res, Dow Agrosciences Llc filed Critical Thompson Boyce Plant Res
Application granted granted Critical
Publication of ATE473271T1 publication Critical patent/ATE473271T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/117—Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/68—Stabilisation of the vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT04751538T 2003-05-05 2004-05-04 Vektoren und zellen zur herstellung von aus transgenen pflanzen gewonnenen immunprotektiven zusammensetzungen ATE473271T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46799803P 2003-05-05 2003-05-05
PCT/US2004/014182 WO2004098533A2 (en) 2003-05-05 2004-05-04 Vectors and cells for preparing immunoprotective compositions derived from transgenic plants

Publications (1)

Publication Number Publication Date
ATE473271T1 true ATE473271T1 (de) 2010-07-15

Family

ID=33435152

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04751538T ATE473271T1 (de) 2003-05-05 2004-05-04 Vektoren und zellen zur herstellung von aus transgenen pflanzen gewonnenen immunprotektiven zusammensetzungen

Country Status (13)

Country Link
US (3) US7132291B2 (de)
EP (1) EP1620550B1 (de)
KR (1) KR20060035596A (de)
CN (1) CN100393870C (de)
AR (1) AR044246A1 (de)
AT (1) ATE473271T1 (de)
AU (1) AU2004235813B2 (de)
BR (1) BRPI0410340A (de)
CA (1) CA2524293A1 (de)
DE (1) DE602004028004D1 (de)
NZ (1) NZ543348A (de)
WO (1) WO2004098533A2 (de)
ZA (1) ZA200508930B (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0410562B8 (pt) 2003-05-22 2021-05-25 Fralunhofer Usa Inc proteína de veículo e seu método de produção em uma planta, ácido nucleico isolado, vetor de expressão e célula hospedeira
CN1326998C (zh) * 2004-11-25 2007-07-18 中国农业科学院哈尔滨兽医研究所 编码h5亚型禽流感病毒血凝素蛋白的基因及其应用
CA2616859C (en) 2005-08-03 2015-04-14 Fraunhofer Usa, Inc. Compositions and methods for production of immunoglobulins
US7553666B2 (en) * 2005-11-04 2009-06-30 Dow Agrosciences Llc Preparation of vaccine master cell lines using recombinant plant suspension cultures
WO2008048344A2 (en) * 2006-02-13 2008-04-24 Fraunhofer Usa, Inc. Bacillus anthracis antigens, vaccine compositions, and related methods
KR20080106434A (ko) * 2006-02-13 2008-12-05 프라운호퍼 유에스에이, 인코포레이티드 Ｈｐｖ 항원, 백신 조성물 및 관련된 방법
JP2009526526A (ja) * 2006-02-13 2009-07-23 フラウンホーファー ユーエスエー， インコーポレイテッド インフルエンザ抗原、ワクチン組成物、および関連する方法
AR060565A1 (es) * 2006-04-21 2008-06-25 Dow Agrosciences Llc Vacuna para la gripe aviaria y metodos de uso
KR100766775B1 (ko) * 2006-04-24 2007-11-01 대한민국 장출혈성대장균(ｅｈｅｃ) 감염증 예방용 톡소이드 백신
CN100487119C (zh) * 2006-05-09 2009-05-13 中国农业科学院哈尔滨兽医研究所 表达禽流感病毒H5亚型HA蛋白的重组新城疫LaSota弱毒疫苗株
AU2007261196A1 (en) * 2006-06-16 2007-12-27 Dow Agrosciences Llc Novel dna sequences, vectors and proteins of avian influenza hemagglutinin
US20080241188A1 (en) * 2007-03-30 2008-10-02 Zeon Corporation Turkey herpesvirus vectored recombinant containing avian influenza genes
BRPI0810865A2 (pt) * 2007-04-28 2017-05-09 Fraunhofer Usa Inc antígenos de tripanossoma, composições vacinais, e métodos relacionados
CN101918559A (zh) * 2007-06-15 2010-12-15 麦迪卡格公司 修饰植物中的糖蛋白产生
KR100964462B1 (ko) * 2007-07-10 2010-06-16 성균관대학교산학협력단 형질전환 식물 유래의 조류독감 바이러스 백신 및 그 제조방법
WO2009009759A2 (en) 2007-07-11 2009-01-15 Fraunhofer Usa, Inc. Yersinia pestis antigens, vaccine compositions, and related methods
CA2615372A1 (en) * 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
BRPI0815662A2 (pt) * 2007-08-20 2016-09-27 Fraunhofer Usa Inc vacinas, antígenos, composições, e métodos profilácticos e terapêuticos para gripe
PT2610345E (pt) 2007-11-27 2016-01-11 Medicago Inc Partículas semelhantes ao vírus (vlps) da gripe recombinantes produzidas em plantas transgénicas que expressam hemaglutinina
EA034733B1 (ru) 2008-01-21 2020-03-13 Медикаго Инк. Нуклеиновая кислота для увеличенной экспрессии гемагглютинина вируса гриппа в растении и ее применение
EP2294202B1 (de) 2008-07-08 2015-05-20 Medicago Inc. Lösliche rekombinante influenza-antigene
CN102165062B (zh) * 2008-07-18 2017-09-08 麦迪卡格公司 新的流感病毒免疫表位
US8734803B2 (en) 2008-09-28 2014-05-27 Ibio Inc. Humanized neuraminidase antibody and methods of use thereof
US9233148B2 (en) * 2009-01-09 2016-01-12 Samuel Bogoch Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
CA2787099A1 (en) 2009-03-30 2010-10-14 Anice C. Lowen Influenza virus hemagglutinin polypeptides containing stem domains, vaccines and uses thereof
JP5871796B2 (ja) 2009-06-24 2016-03-01 メディカゴ インコーポレイテッド ヘマグルチニンを含むキメラインフルエンザウイルス様粒子
ES2662778T3 (es) * 2009-09-22 2018-04-09 Medicago Inc. Método de preparación de proteínas derivadas de plantas
US8784819B2 (en) 2009-09-29 2014-07-22 Ibio Inc. Influenza hemagglutinin antibodies, compositions and related methods
IN2012DN06278A (de) 2009-12-28 2015-09-25 Dsm Ip Assets Bv
KR20120101572A (ko) * 2009-12-28 2012-09-13 메리얼 리미티드 재조합 ｎｄｖ 항원 및 이의 용도
US9701723B2 (en) 2010-02-18 2017-07-11 Icahn School Of Medicine At Mount Sinai Vaccines for use in the prophylaxis and treatment of influenza virus disease
CN102939103A (zh) 2010-03-30 2013-02-20 西奈山医学院 流感病毒疫苗及其应用
SG190031A1 (en) 2010-10-27 2013-06-28 Philip Morris Prod Methods for capturing virus like particles from plants using expanded bed chromatography
TWI620816B (zh) 2011-03-23 2018-04-11 苜蓿股份有限公司 植物衍生蛋白回收方法
KR20140068205A (ko) 2011-09-20 2014-06-05 마운트 시나이 스쿨 오브 메디슨 인플루엔자 바이러스 백신 및 이의 용도
CN116218900A (zh) * 2011-09-30 2023-06-06 麦迪卡格公司 增加植物中病毒样颗粒的产率
US11390878B2 (en) 2011-09-30 2022-07-19 Medicago Inc. Increasing protein yield in plants
KR20150104117A (ko) 2012-12-18 2015-09-14 이칸 스쿨 오브 메디슨 엣 마운트 시나이 인플루엔자 바이러스 백신 및 그의 용도
WO2014159960A1 (en) 2013-03-14 2014-10-02 Icahn School Of Medicine At Mount Sinai Antibodies against influenza virus hemagglutinin and uses thereof
US12467058B2 (en) 2013-03-28 2025-11-11 Aramis Biotechnologies Inc. Influenza virus-like particle production in plants
EP2978848B1 (de) 2013-03-28 2020-05-06 Medicago Inc. Herstellung influenzavirus-ähnlicher partikel in pflanzen
US11441150B2 (en) 2014-01-10 2022-09-13 Medicago Inc. CPMV enhancer elements
US10736956B2 (en) 2015-01-23 2020-08-11 Icahn School Of Medicine At Mount Sinai Influenza virus vaccination regimens
WO2017218624A1 (en) 2016-06-15 2017-12-21 Icahn School Of Medicine At Mount Sinai Influenza virus hemagglutinin proteins and uses thereof
WO2018187706A2 (en) 2017-04-07 2018-10-11 Icahn School Of Medicine At Mount Sinai Anti-influenza b virus neuraminidase antibodies and uses thereof
EP3810634A4 (de) 2018-06-21 2022-07-27 Icahn School of Medicine at Mount Sinai Mosaik-influenzavirus-hämagglutinin-polypeptide und deren verwendungen
EP3959216A4 (de) 2019-04-24 2023-01-11 Icahn School of Medicine at Mount Sinai Neuraminidase-antikörper gegen influenza-b-virus und verwendungen davon
CN117999352A (zh) * 2021-08-24 2024-05-07 富优基尼以色列股份有限公司 用于植物细胞的序列和启动子以及制备和使用此类序列的方法
WO2023237726A1 (en) * 2022-06-10 2023-12-14 Pantarhei Oncology B.V. An intracellular tumor-specific variant of human zona pellucida glycoprotein 3 and nucleic acids coding therefor for use in the treatment of cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04501801A (ja) * 1988-09-06 1992-04-02 ワシントン ユニバーシティ トランスジェニック植物による経口的免疫化
US20010053367A1 (en) * 1991-08-26 2001-12-20 Prodigene, Inc. Vaccines expressed in plants
US6034298A (en) * 1991-08-26 2000-03-07 Prodigene, Inc. Vaccines expressed in plants
US5612487A (en) * 1991-08-26 1997-03-18 Edible Vaccines, Inc. Anti-viral vaccines expressed in plants
US5426108A (en) * 1993-11-10 1995-06-20 American Cyanamid Company Antibiotic 31F508 ALPHA1, ALPHA2, BETA1 and BETA2
ES2235176T3 (es) * 1994-10-24 2005-07-01 THE TEXAS A & M UNIVERSITY SYSTEM Inmunizacion oral con plantas transgenicas.
ES2219679T3 (es) * 1995-10-18 2004-12-01 Akzo Nobel N.V. Vacuna de combinacion contra la enfermedad de newcastle.
US6395964B1 (en) * 1995-10-24 2002-05-28 The Texas A&M University System Oral immunization with transgenic plants
EP0974660A1 (de) 1998-06-19 2000-01-26 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Newcastle-Krankheitsvirus Infektiöser Klone, Impfstoffe und Diagnosetest
WO2002000169A2 (en) * 2000-06-26 2002-01-03 The United States Of America, As Represented By The Secretary Of Agriculture Production of vaccines using transgenic plants
BR0208880A (pt) 2001-04-13 2004-12-07 Thompson Boyce Plant Res Métodos para produzir um homogeneizado seco estável de uma planta transgênica que expressa uma proteìna heteróloga, para prevenir uma doença patogênica em um animal, para liberar uma proteìna transgênica a um animal, de contracepção e para induzir uma resposta imune mucosal, homogeneizado seco estável, composição farmacêutica, planta transgênica, célula de planta, vetor plasmìdico para transformar uma célula de planta, composição de alimento, e, alimento

Also Published As

Publication number Publication date
US20050048074A1 (en) 2005-03-03
DE602004028004D1 (de) 2010-08-19
CN1788077A (zh) 2006-06-14
EP1620550A4 (de) 2006-06-14
KR20060035596A (ko) 2006-04-26
CN100393870C (zh) 2008-06-11
AR044246A1 (es) 2005-09-07
NZ543348A (en) 2008-08-29
US7407802B2 (en) 2008-08-05
EP1620550B1 (de) 2010-07-07
AU2004235813B2 (en) 2010-07-29
CA2524293A1 (en) 2004-11-18
WO2004098533A3 (en) 2005-08-04
AU2004235813A1 (en) 2004-11-18
US20090017065A1 (en) 2009-01-15
BRPI0410340A (pt) 2006-05-30
WO2004098533A2 (en) 2004-11-18
EP1620550A2 (de) 2006-02-01
US7132291B2 (en) 2006-11-07
US20080076177A1 (en) 2008-03-27
ZA200508930B (en) 2007-03-28

Similar Documents

Publication Publication Date Title
ATE473271T1 (de) Vektoren und zellen zur herstellung von aus transgenen pflanzen gewonnenen immunprotektiven zusammensetzungen
ATE505548T1 (de) Insektizidzusammensetzungen und verfahren zur herstellung von insektenbeständigen transgenen pflanzen
EP1635772A4 (de) Stabile immunoprophylaktische und therapeutische zusammensetzungen aus transgenen pflanzenzellen und herstellungsverfahren
DE602006012283D1 (de) Integrierte schaltung und verfahren zu ihrer herstellung
EP1968124A4 (de) Halbleiter-leuchtelement und prozess zu seiner herstellung
EP1626621A4 (de) Pflanzenzüchtungsverfahren
DE502004008318D1 (de) Speicher-schaltungsanordnung und verfahren zur herstellung
ATE434388T1 (de) Fermentierte produkte aus sojafaserstoffpartikel und verfahren ihrer herstellung
EP1838846A4 (de) Verfahren und zusammensetzungen zur verkapselung von zellen
ATE401409T1 (de) Verfahren und vektoren zur herstellung von transgenen pflanzen
EP1919447A4 (de) Zusammensetzungen und verfahren zur herstellung und verwendung von nanoemulsionen
DE602004021001D1 (de) Fettsäuredesaturasen aus primula
DE60337036D1 (de) Halbleiterbauelement und verfahren zu seiner herstellung
DE602004003071D1 (de) Verfahren zur herstellung von ammoniak aus wasser und stickstoff am einsatzort
DE60327066D1 (de) Saure protein- und ballaststoffhaltige zusammensetzungen und verfahren zu ihrer herstellung
DE602004027131D1 (de) Aktuatoren aus formgedächtnislegierungen
DE602006012972D1 (de) Mikronisierte tanaproget zusammensetzungen und verfahren zu ihrer herstellung
DE602004009011D1 (de) Kristallinisches Material IM-12 und Verfahren zu seiner Herstellung
DE60333840D1 (de) Geformte absorbierende auflagen und verfahren zur dessen herstellung
DK1962604T3 (da) Plantevækstregulerende sammensætninger
ATE418270T1 (de) Verfahren zur herstellung von polyphenol angereicherten zusammensetzungen aus kakaoschale
DE502004006260D1 (de) Verfahren zur herstellung von 1-octen aus crack-c4
DE602005026176D1 (de) Rollenlose spule und verfahren zu ihrer herstellung
DE502006009351D1 (de) Feinteiliges azopigment und verfahren zu seiner herstellung
DE502005002287D1 (de) FARBIGES TRANSPARENTES KORUNDMATERIAL MIT POLYKRISTALLINEM SUB-õM GEFÜGE UND VERFAHREN ZUR HERSTELLUNG VON FORMKÖRPERN AUS DIESEM MATERIAL

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties